Site use by people with disabilities
The OFDT site has been adapted to make it easier to be used by people with disabilities.
A site plan is available at the top right of each page of the website, under the search engine, to enable you to easily orient yourself in the first three structural levels.
It is possible to increase font size using the "Increase font size" button present on each website page. This is at the upper right of the pages, except for the home page, in which it is located at the bottom right. It is demonstrated in this visual:
Moreover, there is replacement text for each of the site's images to make it easier to read the pages when being used by a text-based browser or a screen reader (Lynx, JAWS).
Along the same lines, each website page has avoidance links making the page content easy to access from the menu or the search engine.
If you have a disability, please give us your feedback and suggestions to improve the site by writing to the following address: webmestre[a]ofdt[dot]fr (replace [a] with the at-sign and [dot] with a .), or by using the site's contact us form.
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
